Assessment of the incidence of surgical site infections after surgery for colorectal cancer with preoperative oral antibiotics.

Assessment of the incidence of surgical site infections after surgery for colorectal cancer with preoperative oral antibiotics. - Assessment of the incidence of surgical site infections after surgery for colorectal cancer with preoperative oral antibiotics.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037301

Enrollment

100

Registered

2019-07-15

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with surgery forcolorectal cancer

Interventions

oral antibiotics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with colorectal cancer, who will perform laparoscopic surgery.

Exclusion criteria

Exclusion criteria: Patients with allergy for Ciprofloxacin and Metronidazole. Patients who have difficulty with oral administration due to intestinal obstruction.

Design outcomes

Primary

Measure	Time frame
The rate of surgical site infection at 30th days after surgery	—

Secondary

Measure	Time frame
Safety of the preoperative oral antibiotics and, Incidence of postoperative suture failure, incidence of postoperative ileus, incidence of urinary tract infection	—

Countries

Japan

Contacts

Public ContactSoichiro Natsume

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Colorectal surgery

natsumesoh16@cick.jp03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026